US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Stage

0.3754

+0.0000

Volume:- -

Turnover:- -

Market Cap:10.85M

PE:-0.11

High:0.3754

Open:0.3754

Low:0.3754

Close:0.3754

Loading ...

Overview Company News Filings

Cheniere Energy (NYSE:LNG) Marks Milestone With Completion Of Train 1 At Corpus Christi Stage 3

Simply Wall St.

Jensen Huang Takes Center Stage: What to Expect from Nvidia’s Big GTC 2025 Keynote

AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer

Cheniere Announces Substantial Completion of Train 1 at the Corpus Christi Stage 3 Project

Commentary: A stronger sports system is taking shape in Singapore, but the hard work is not over

Hong Kong’s Fintech Ecosystem Expands as Blockchain, AI, and Digital Assets Take Center Stage

Cautious Hold Rating on Editas Medicine Amid Early Development Stage and Long-Term Milestones

Ulta Beauty's Soft 2025 Earnings Guidance Sets Stage For Outperformance, UBS Says

EF Foundation's Self-Salvation: Ashley Wang "Takes the Stage," Technical Bureaucrats on the Rise

Pangaea Logistics Solutions Ltd. Reports Financial Results for the Three Months and Year Ended December 31, 2024

2 Problems You Might Run Into if You Try to Live Off Social Security Alone

Navitas Drives a Paradigm Shift in Power with Single-Stage Bi-Directional Switch (BDS) Converters

EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity

Palantir’s Latest Wave of Customers Take Center Stage at AIPCon

JPMorgan Chase (NYSE:JPM) Sees 4% Quarterly Dip As Leadership Restructuring Takes Center Stage

Simply Wall St.

Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SSI/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","market":"US","secType":"STK","nameCN":"Stage","latestPrice":0.3754,"timestamp":1588968000000,"preClose":0.3754,"halted":3,"volume":0,"delay":0,"floatShares":20307519,"shares":28911336,"eps":-3.332056,"marketStatus":"Halted","change":0,"latestTime":"04-01 17:17:29 EDT","open":0.3754,"high":0.3754,"low":0.3754,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.332056,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1743552000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":998884800000,"exchange":"NYSE","adjPreClose":0.3754,"dividendRate":0.133191,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","floatShares":20307519,"roa":"-3.54%","roe":"-44.60%","lyrEps":-3.1264,"shares":28911336,"dividePrice":0.05,"high":0.3754,"amplitude":0,"preClose":0.3754,"low":0.3754,"week52Low":0.27,"pbRate":"0.07","week52High":9.5,"institutionHeld":0.5253,"latestPrice":0.3754,"eps":-3.332056,"divideRate":0.133191,"volume":0,"delay":0,"ttmEps":-3.332056,"open":0.3754,"prevYearClose":8.12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SSI\",pageSize:16,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520933554","title":"Cheniere Energy (NYSE:LNG) Marks Milestone With Completion Of Train 1 At Corpus Christi Stage 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2520933554","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520933554?lang=en_us&edition=fundamental","pubTime":"2025-03-19 01:56","pubTimestamp":1742320585,"startTime":"0","endTime":"0","summary":"Cheniere Energy recently marked the substantial completion of Train 1 at its Corpus Christi Stage 3 Liquefaction Project, a development that may impact its operations and potentially its stock performance. This milestone adds to Cheniere's growing LNG capacity and aligns with its strategic expansion goals. Despite this positive development, the company's 5.62% price increase over the last quarter comes amid a broader market downturn, with indices like the Dow Jones and S&P 500 experiencing declines. Cheniere's performance contrasts with the overall negative sentiment in the market, possibly due to its product-related announcements that emphasized growth and completion timelines. Additionally, the company reported lower financial metrics, including revenue and earnings, which did not appear to affect its stock adversely during this period. This resilience and focus on completing key projects like Train 1 may have helped sustain investor confidence and contributed to its share price incr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cheniere-energy-nyse-lng-marks-175625633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LNG","LU0630314457.HKD","LU0345780950.USD","LU0314104364.USD","LU2449327464.USD","SSI","LU0048573561.USD","LU0368265418.SGD","NYSE","LU0788109394.HKD","LU0742534661.SGD","LU0170899867.USD","LU0345770993.USD","LU0251142724.SGD","LU0345781412.USD","BK4144","LU0251131958.USD","IE00B29SXK94.USD","LU0345770308.USD","IE00B29SXL02.USD","LU0122376428.USD"],"gpt_icon":0},{"id":"2520178640","title":"Jensen Huang Takes Center Stage: What to Expect from Nvidia’s Big GTC 2025 Keynote","url":"https://stock-news.laohu8.com/highlight/detail?id=2520178640","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520178640?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:35","pubTimestamp":1742294112,"startTime":"0","endTime":"0","summary":"NVIDIA’s ($NVDA) GTC 2025 is here and is one of the year’s biggest tech events. Running from March 17-21, this four-day conference is all about the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/jensen-huang-takes-center-stage-what-to-expect-from-nvidias-big-gtc-2025-keynote?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/jensen-huang-takes-center-stage-what-to-expect-from-nvidias-big-gtc-2025-keynote?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0175139822.USD","NVD3.UK","2NVD.UK","NVDS","NVDD","NVDS.UK","LU0943347566.SGD","LU0353189680.USD","LU0868494617.USD","LU1629891620.HKD","NVDY","SSI","3NVD.UK","LU1989764664.SGD","LU0823434740.USD","LU1064131342.USD","IE0034235295.USD","SG9999015952.SGD","LU1989764748.USD","LU2756315664.SGD","IE00BJTD4V19.USD","IE00B19Z8W00.USD","LU1674673428.USD","LU1868836591.USD","GB00BDT5M118.USD","LU1935043023.USD","LU1244550577.SGD","LU1720051017.SGD","LU2125909916.SGD","LU1548497426.USD","NVD","LU2750360997.AUD","LU2087621335.USD","SG9999015358.SGD","LU2417539215.USD","LU2097344431.USD","LU0077335932.USD","LU2168564065.EUR","NVDA","IE00BKVL7J92.USD","NVD2.UK","NVDU","LU0107464264.USD","LU0965509283.SGD","SNVD.UK","NVIW.SI","LU1861127337.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2520570285","title":"AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2520570285","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520570285?lang=en_us&edition=fundamental","pubTime":"2025-03-17 23:10","pubTimestamp":1742224200,"startTime":"0","endTime":"0","summary":"AstraZeneca AZN recently announced that the European Commission has approved its blockbuster cancer drug Imfinzi  as monotherapy for treating limited-stage small cell lung cancer  in adult patients whose disease has not progressed following platinum-based chemoradiation therapy .The latest approval for Imfinzi in the European Union  was based on data from the phase III ADRIATIC study.Data from the phase III ADRIATIC study showed that treatment with Imfinzi reduced the risk of death by 27% as compared to placebo. Additionally, treatment with Imfinzi reduced the risk of disease progression or death by 24% versus placebo.The approval in the EU was expected as the Committee for Medicinal Products for Human Use recommended approval of Imfinzi as monotherapy for treating LS-SCLC in adult patients whose disease has not progressed following platinum-based CRT in February 2025.The FDA approved Imfinzi for a similar indication in December 2024.Hypoparathyroidism patients suffer from a deficiency","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azns-imfinzi-gets-eu-nod-151000804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BMRN","LU1829250122.USD","DVAX","LU0320765992.SGD","LU2417539215.USD","LU0889565916.HKD","LU2456880835.USD","AZN","BK4566","LU0109394709.USD","BK4213","BK4139","BK4156","CRT","BK4568","LU2236285917.USD","IE00B7SZLL34.SGD","LU2462157665.USD","SSI","BK4007","BK4588","ARVN","BK4585","IE0002270589.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2520081527","title":"Cheniere Announces Substantial Completion of Train 1 at the Corpus Christi Stage 3 Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2520081527","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520081527?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:30","pubTimestamp":1742214600,"startTime":"0","endTime":"0","summary":"HOUSTON, March 17, 2025----Cheniere Energy, Inc.   today announced that Substantial Completion of Train 1 at the Corpus Christi Stage 3 Liquefaction Project  was achieved on March 16, 2025. Commissioning is complete and Cheniere’s engineering, procurement and construction partner, Bechtel Energy, Inc.  has turned over care, custody, and control of Train 1 and associated systems to Cheniere. With the achievement of Substantial Completion, financial results from liquefied natural gas  sales from Train 1 going forward will be reflected in the statement of operations of Cheniere and its applicable affiliates.\"The substantial completion of the first train of CCL Stage 3 - ahead of schedule and on budget - marks another important milestone for Cheniere and further builds upon the track record of excellence in execution consistently delivered by the Cheniere and Bechtel teams,\" said Jack Fusco, Cheniere’s President and Chief Executive Officer. \"We remain focused on safely and efficiently brin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cheniere-announces-substantial-completion-train-123000516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4144","LU0251131958.USD","LU0314104364.USD","BK4588","IE00B29SXL02.USD","LU0251142724.SGD","LU0345781412.USD","BK4585","LU0345770308.USD","LU0788109394.HKD","SSI","LU0122376428.USD","LU0345770993.USD","LU2449327464.USD","LU0048573561.USD","LNG","BK4547","LU0170899867.USD","LU0742534661.SGD","BK4517","LU0368265418.SGD","IE00B29SXK94.USD","CCL","BK4142","LU0630314457.HKD","LU0345780950.USD"],"gpt_icon":0},{"id":"2520629095","title":"Commentary: A stronger sports system is taking shape in Singapore, but the hard work is not over","url":"https://stock-news.laohu8.com/highlight/detail?id=2520629095","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520629095?lang=en_us&edition=fundamental","pubTime":"2025-03-17 06:00","pubTimestamp":1742162400,"startTime":"0","endTime":"0","summary":"Singapore’s aspiring athletes now have more funding and support than ever before, says former national fencer and NMP Nicholas Fang.","market":"nz","thumbnail":"https://dam.mediacorp.sg/image/upload/s--E7uaF730--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2024/08/19/kallang_1.jpg?itok=BAkBKUBm","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--E7uaF730--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2024/08/19/kallang_1.jpg?itok=BAkBKUBm"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/commentary/singapore-sports-development-athletes-funding-support-kallang-5003791","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["SSP","BK4125","SSI"],"gpt_icon":0},{"id":"2519812397","title":"Hong Kong’s Fintech Ecosystem Expands as Blockchain, AI, and Digital Assets Take Center Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2519812397","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519812397?lang=en_us&edition=fundamental","pubTime":"2025-03-15 17:54","pubTimestamp":1742032463,"startTime":"0","endTime":"0","summary":"Hong Kong’s fintech sector is experiencing rapid growth, with blockchain, digital assets, distributed ledger technology , and artificial intelligence  driving innovation.According to the latest Hong Kong Fintech Ecosystem report by InvestHK, the region now hosts over 1,100 fintech firms, including 175 blockchain-focused companies and 111 digital asset and cryptocurrency firms—marking a 250% and 30% increase, respectively, since 2022.The report also highlights that over 73% of fintech firms in Hong Kong focus on AI, significantly outpacing the 41.5% engaged in digital assets and cryptocurrency. Hong Kong’s unique advantage under China’s “one country, two systems” policy allows it to operate a free-market economy with unrestricted capital flow and strong international trade ties while maintaining close links to mainland China.Leveraging these strengths, the Hong Kong government has rolled out several Web3 innovations, including a licensing regime, spot Bitcoin and Ether exchange-traded f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67d54e505fa75a693d35f015/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["SSI","FTVI"],"gpt_icon":0},{"id":"2519337046","title":"Cautious Hold Rating on Editas Medicine Amid Early Development Stage and Long-Term Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2519337046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519337046?lang=en_us&edition=fundamental","pubTime":"2025-03-15 04:15","pubTimestamp":1741983358,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Soumit Roy has reiterated their neutral stance on EDIT stock, giving a Hold rating on March 6. Soumit Roy has given his Hold r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cautious-hold-rating-on-editas-medicine-amid-early-development-stage-and-long-term-milestones?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cautious-hold-rating-on-editas-medicine-amid-early-development-stage-and-long-term-milestones?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EDIT","SSI"],"gpt_icon":0},{"id":"2519543380","title":"Ulta Beauty's Soft 2025 Earnings Guidance Sets Stage For Outperformance, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2519543380","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519543380?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:42","pubTimestamp":1741966940,"startTime":"0","endTime":"0","summary":"Ulta Beauty's  full-year guidance missed Wall Street's estimates, but showed potential for positive earnings revisions in the coming quarters, UBS said in a Friday client note.Ulta expects selling, general and administrative expenses to increase 10% for the year. Bulls view that as conservative, leaving \"potential upside risk to EPS estimates,\" UBS analysts led by Michael Lasser wrote in the note.\"In the near-term, the  has continued to manage  EPS expectations well,\" Lasser said. \"We think Ulta's guidance leaves room for positive estimate revisions over the next few quarters.\". Ulta forecasts promotional environment to remain \"rational\" this year and does not see a significant impact from tariffs compared with peers, UBS said. These factors can support the retailer's profitability.However, Ulta's guidance still indicates some ongoing pressure for its beauty category this year, UBS said.For the fiscal fourth quarter, Ulta's EPS rose to $8.46 from $8.08 last year, compared with the Fact","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ulta-beauty-apos-soft-2025-154220960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ULTA","SSI"],"gpt_icon":0},{"id":"2519814147","title":"EF Foundation's Self-Salvation: Ashley Wang \"Takes the Stage,\" Technical Bureaucrats on the Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2519814147","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519814147?lang=en_us&edition=fundamental","pubTime":"2025-03-14 11:12","pubTimestamp":1741921920,"startTime":"0","endTime":"0","summary":"Original Article Title: \"Who Will Save Ethereum from the 'Midlife Crisis'?\"Original Article Author: Ethan, Odaily Planet DailyOn March 10, 2025, the Ethereum Foundation  announced that Hsiao-Wei Wang had been promoted to the board of directors, becoming the first ethnic Chinese leader to be promoted from a technical background to the board of directors in the seven-year history of the EF. This appointment is seen as a key signal of the EF's response to the ecosystem crisis and the restructuring of its governance system—in the context of Ethereum facing challenges such as the Solana ecosystem impact, Layer 2 ecosystem fragmentation, and community trust deficit, a rise of technical bureaucrats may herald a silent revolution.Who is Hsiao-Wei Wang?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info/en/news/57289","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_highlight","symbols":["FETH","ETH.USD.CC","UNI.USD.HKCC","ETH","ETHV","EZET","ETH.USD.HKCC","UNI.USD.CC","CETH","QETH","BK4601","OP.USD.HKCC","LDO.USD.HKCC","AAVE.USD.HKCC","SOL.USD.HKCC","AAVE.USD.CC","SSI"],"gpt_icon":0},{"id":"2519861328","title":"Pangaea Logistics Solutions Ltd. Reports Financial Results for the Three Months and Year Ended December 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2519861328","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519861328?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:19","pubTimestamp":1741897140,"startTime":"0","endTime":"0","summary":"NEWPORT, R.I., March 13, 2025 /PRNewswire/ -- Pangaea Logistics Solutions Ltd.  , a global provider of comprehensive maritime logistics solutions, announced today its results for the three months and year ended December31, 2024.Net income attributable to Pangaea Logistics Solutions Ltd. of $8.4 million, or $0.18 per diluted share. Adjusted net income attributable to Pangaea Logistics Solutions Ltd. of $7.6 million, or $0.16 per diluted share. Time Charter Equivalent  rates earned by Pangaea of $15,942 per day. Pangaea's TCE rates exceeded the average Baltic Panamax and Supramax indices by 48%. Net income attributable to Pangaea Logistics Solutions Ltd. of $28.9 million, or $0.63 per diluted share. For the full year ended December31, 2024, Pangaea reported non-GAAP adjusted net income of $29.9 million or $0.65 per diluted share, on total revenues of $536.5 million. Adjusted EBITDA was $83.0 million for the full year 2024, reflecting an adjusted EBITDA margin of 15.6%, compared to 16.0% ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/pangaea-logistics-solutions-ltd-reports-201900616.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pangaea-logistics-solutions-ltd-reports-201900616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4581","BK4585","SSI","BK4021","BK4588","BK4590","BK4561","ET","BK4144","PANL"],"gpt_icon":0},{"id":"2519968831","title":"2 Problems You Might Run Into if You Try to Live Off Social Security Alone","url":"https://stock-news.laohu8.com/highlight/detail?id=2519968831","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519968831?lang=en_us&edition=fundamental","pubTime":"2025-03-13 21:00","pubTimestamp":1741870800,"startTime":"0","endTime":"0","summary":"Social Security was only intended to cover 40% of pre-retirement income for average earners.Its buying power may decline in the future.Supplementing your checks with income from a job or government benefits may increase your standard of living.Ideally, you'd be able to supplement your checks with personal savings. But if that isn't possible, you may have other options. If you're still able to work, you could take on a part-time job or opt for a phased retirement where you gradually reduce your hours over time.You can also check to see whether you qualify for government benefits that could help you cover your essential expenses. If you're over 65, you'll probably be eligible for Medicare for healthcare expenses. You may be eligible","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/retirement/2025/03/13/problems-if-you-live-on-social-security-alone/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["SSI"],"gpt_icon":0},{"id":"2519724836","title":"Navitas Drives a Paradigm Shift in Power with Single-Stage Bi-Directional Switch (BDS) Converters","url":"https://stock-news.laohu8.com/highlight/detail?id=2519724836","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519724836?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:30","pubTimestamp":1741869000,"startTime":"0","endTime":"0","summary":"Bi-Directional GaNFast plus new IsoFast drivers enable advanced ‘single-stage’ topologies to further enhance efficiency, power density, and performance in AC-DC and AC-AC conversion.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/13/3042192/0/en/Navitas-Drives-a-Paradigm-Shift-in-Power-with-Single-Stage-Bi-Directional-Switch-BDS-Converters.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4084","LU1861219969.SGD","BK4605","BK4588","LU1720051017.SGD","LU0724618433.USD","LU1720051108.HKD","PW","LU1978683503.SGD","BK4585","LU0124384867.USD","BK4211","LU1854103824.USD","PFC","ON","BK4513","IE00BD6J9T35.USD","LU1548497426.USD","LU1861214812.USD","BK4512","LU1093756325.SGD","LU1854104046.USD","LU1861220033.SGD","SSI","BK4234","BK4141","SWCH","LU0348723411.USD","LU2360107325.USD","BK4195","LU1861215975.USD","BK4116","IE00BZ199S13.USD","LU2357305700.SGD","LU2298322129.HKD","LU1093756168.USD"],"gpt_icon":0},{"id":"2519617835","title":"EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2519617835","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519617835?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863637,"startTime":"0","endTime":"0","summary":"On Thursday, Vivani Medical, Inc.  announced the administration of its first GLP-1  implant in the LIBERATE-1 trial in Australia.Vivani's lead program, NPM-115, utilizes a miniature, six-month, subdermal, GLP-1  implant under development for chronic weight management in obese or overweight individuals.Also Read: EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value. The company also announced full enrollment in the LIBERATE-1 study, which was achieved four weeks after the first subject enrolled, and reaffirmed that top-line results should be available in mid-2025.In December, Vivani Medical initiated screening and enrollment at two centers in Australia for the first-in-human LIBERATE-1 trial.The LIBERATE-1 study is exploring the full pharmacokinetic profile of NPM-115, which has demonstrated consistently smooth and minimally fluctuating drug release in vitro and in animal models.LIBERATE-1 is a Phas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-vivani-medical-announces-first-110037673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","LU2417539215.USD","AZN","LU1829250122.USD","LU0154236417.USD","BK4007","IE00BKVL7J92.USD","LU2236285917.USD","SSI","GLP","LU0889565916.HKD","BK4532","BK4144","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4568","LU0320765992.SGD","LU1093756325.SGD","BK4590","LU0109394709.USD","BK4585","LU2462157665.USD","LU2456880835.USD","BK4588","VANI","BK4599"],"gpt_icon":1},{"id":"2518772593","title":"Palantir’s Latest Wave of Customers Take Center Stage at AIPCon","url":"https://stock-news.laohu8.com/highlight/detail?id=2518772593","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518772593?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:01","pubTimestamp":1741723260,"startTime":"0","endTime":"0","summary":"DENVER, March 11, 2025----Palantir Technologies Inc.  announced today that it will host its sixth AIPCon on Thursday, March 13, with exclusive content available for online viewers starting 20 minutes before the start of the live stream.New customer announcements include Heineken, Walgreens, R1 RCM, RaceTrac, Ripcord, and more. The next wave of Warp Speed customers will also showcase how they are re-industrializing American manufacturing, including Red Cat, Saildrone, Saronic, SNC, and Ursa Major. Other customer speakers include AT&T, Anduril, TWG Global, Lennar, KKR, Owens Corning, Delta Air Lines, L3Harris, Parexel, Wendy’s QSCC, JD Power, and many more.AIPCon will be available via live stream on Thursday, March 13, 2025. For questions about joining the waitlist to attend in-person, please email aipcon-2025@palantir.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/palantir-latest-wave-customers-center-200100787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861559042.SGD","BK4585","BK4588","LU1861558580.USD","CUBI","SSI","BK4613","BK4547","BK4211","PLTR","BK4023","BK4543"],"gpt_icon":1},{"id":"2518778730","title":"JPMorgan Chase (NYSE:JPM) Sees 4% Quarterly Dip As Leadership Restructuring Takes Center Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2518778730","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518778730?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:57","pubTimestamp":1741715842,"startTime":"0","endTime":"0","summary":"JPMorgan Chase recently appointed long-time executives Matt Sable and Melissa Smith as co-heads of its commercial banking division in the US and Canada, a move reflecting an emphasis on leadership restructuring. Over the last quarter, the company’s stock saw a decline of 4.38%, amidst broader market retreat influenced by investor apprehensions surrounding tariffs announced by the Trump administration. This leadership change at JPMorgan is part of a series of organizational adjustments, including the retirement plans of Daniel Pinto and a fresh approach to branch expansions, notably in Alabama. Despite delivering strong financial results with significant year-over-year gains in Q4 net income, the market's overall 4.6% drop, accelerated by concerns about political and economic uncertainty, overshadowed these positive outcomes. The recently completed share buyback program and strong fundamentals were insufficient to counteract broader market volatility, contributing to the stock’s overall","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jpmorgan-chase-nyse-jpm-sees-175722150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2552382058.USD","LU0234572021.USD","LU1244550221.USD","LU0943347566.SGD","NYSE","LU2237443382.USD","JPM","SG9999002224.SGD","LU0211331839.USD","LU2237443978.SGD","LU2756315664.SGD","LU1894683348.USD","LU0964807845.USD","LU0211327993.USD","SSI","BK4585","SG9999002232.USD","IE00BLSP4452.SGD","LU0942090050.USD","LU0820561909.HKD","LU1974910355.USD","LU1914381329.SGD","IE00BJTD4V19.USD","LU0683600562.USD","LU0868494708.USD","IE00BKVL7J92.USD","LU1064131342.USD","LU1720051017.SGD","LU0211326755.USD","IE00BDRTCR15.USD","LU1629891620.HKD","IE00BDCRKT87.USD","LU0149725797.USD","LU1917777945.USD","LU1551013342.USD","LU2264538146.SGD","LU0496365809.HKD","BK4533","LU1244550494.USD","IE00BJLML261.HKD","LU1145028129.USD","LU2430703251.USD","LU0203345920.USD","LU1988902786.USD","LU0882574139.USD","LU2023250330.USD","LU0238689110.USD","LU0251132253.USD","IE00BJTD4N35.SGD","LU2592432038.USD"],"gpt_icon":1},{"id":"2518206234","title":"Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2518206234","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518206234?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:02","pubTimestamp":1741629721,"startTime":"0","endTime":"0","summary":"On Monday, Arrowhead Pharmaceuticals, Inc. released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the company’s investigational RNA interference  therapeutic designed to reduce liver production of complement component 3  as a potential therapy for various complement-mediated diseases.ARO-C3 is designed to reduce hepatocyte production of complement C3 as a potential treatment for various complement-mediated renal diseases.The dysregulated activity of the complement system can contribute to tissue injury and the progression of the disease. By silencing C3, investigational ARO-C3 has the potential to treat complement-mediated renal diseases by modulating the activation of the complement cascade.Also Read: Veren Soars On Whitecap Merger Deal: Details. The company plans to present additional results at a medical meeting in 2025.Pharmacodynamic effects: Maximum mean reduction in C3 of 89% and mean sustained reduction of greater than 87% from baseline through week 24.Maximum mea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-stock-falls-early-180201122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","ARWR","BK4588","BK4139","BK4505","SSI","RNA"],"gpt_icon":0}],"pageSize":16,"totalPage":13,"pageCount":3,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SSI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-21","symbol":"SSI","fiscalQuarterEnding":"2019/10","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1574312400000,"reportTimeType":"pre","actualEps":-0.15},{"date":"2019-08-22","symbol":"SSI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/07","expectedEps":null,"defaultRemindTime":1566460800000,"name":null,"time":"Pre-Market","dateTimestamp":1566446400000,"actualEps":-0.6},{"market":"US","date":"2019-05-23","symbol":"SSI","fiscalQuarterEnding":"2019/04","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1558584000000,"reportTimeType":"pre","actualEps":-1.67},{"market":"US","date":"2019-03-07","symbol":"SSI","fiscalQuarterEnding":"2019/01","expectedEps":0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1551934800000,"reportTimeType":"pre","actualEps":0.25},{"market":"US","date":"2018-12-03","symbol":"SSI","amount":0.05,"name":"Stage Stores Inc","currency":"USD","type":"dividend","dateTimestamp":1543813200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SSI\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-24","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-05-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-08-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-11-27","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2018-03-05","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SSI\",market:\"US\",delay:false,,,undefined,":{}}}